AKYA logo

Akoya Biosciences, Inc. (AKYA)

Profile

Full Name

Akoya Biosciences, Inc.

Ticker

NASDAQ: AKYA

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Instruments & Supplies

Country

United States

IPO

April 16, 2021

Indexes

Not included

Website

https://www.akoyabio.com

Employees

205

Key Details

Price

$1.29

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$81.67M(-15.48% YoY)

Annual EPS

-$1.12(+21.68% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.29
    AKYA price is $1.29

    30-Day Relative Volume

    0.00
    AKYA 30-day relative volume is 0.00

    Price Performance

    Price Most recent change

    -
    AKYA price change on Jul 16, 2025 is unknown

    Price YTD change

    -43.67%
    AKYA price is down -43.67% since January 1st

    Price 1-year change

    -41.1%
    AKYA price is down -41.1% year-on-year

    Price 3-year change

    -91.67%
    AKYA price is down -91.67% over the past 3 years

    Price Range

    Price All-time high

    $28.96
    AKYA price is currently -95.54% below its historical high of $28.96

    Price 3-year low

    $0.93
    AKYA price is currently +38.56% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $64.34M
    AKYA market capitalization is $64.34 million

    Market cap 3-year change

    -89.04%
    AKYA market capitalization is down -89.04% over the past 3 years

    Market cap All-time high

    $929.71M
    AKYA market capitalization is currently -93.08% below its historical high of $929.71 million

    Market cap sector rank

    -
    AKYA market capitalization is unknown

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.76%
    AKYA shares outstanding is up +0.76% year-on-year

    Shares Outstanding 3-Year Change

    +31.62%
    AKYA shares outstanding is up +31.62% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.54
    AKYA beta is 1.54

    200-day SMA

    $1.99
    AKYA price is currently -35.19% below its 200-day simple moving average

    50-day SMA

    $1.22
    AKYA price is currently +5.61% above its 50-day simple moving average

    RSI

    51.85
    AKYA 14-day relative strength index is 51.85

    Volume

    0.00
    AKYA 30-day relative volume is 0.00

    ATR

    $0.02
    AKYA average true range is $0.02

    10-day Historical Volatility

    29.82%
    AKYA 10-day historical volatility is 29.82%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $81.67M
    AKYA annual revenue is $81.67 million

    Revenue Analysts estimate

    $81.47M
    AKYA annual revenue is currently +0.25% higher than the consensus analysts' forecast

    Revenue 1-year change

    -15.48%
    AKYA annual revenue is down -15.48% year-on-year

    Revenue Sector rank

    -
    AKYA annual revenue is unknown

    EPS

    EPS

    -$1.12
    AKYA annual earnings per share is -$1.12

    EPS Analysts estimate

    -$0.86
    AKYA annual earnings per share is currently +29.48% higher than the consensus analysts' forecast

    EPS 1-year change

    +21.68%
    AKYA annual earnings per share is up +21.68% year-on-year

    EPS Sector rank

    -
    AKYA annual earnings per share is unknown

    Profit

    Gross profit

    $47.88M
    AKYA annual gross profit is $47.88 million

    Gross margin

    58.62%
    AKYA annual gross profit margin is 58.62%

    Operating profit

    -$41.18M
    AKYA annual operating income is -$41.18 million

    Operating margin

    -50.43%
    AKYA annual operating profit margin is -50.43%

    Net income

    -$55.37M
    AKYA annual net profit is -$55.37 million

    Net margin

    -67.79%
    AKYA annual net profit margin is -67.79%

    Expenses

    Total expenses

    $122.86M
    AKYA annual total expenses is $122.86 million

    Operating expenses

    $89.06M
    AKYA annual total operating expenses is $89.06 million

    Cost of goods sold

    $33.79M
    AKYA annual cost of goods sold is $33.79 million

    Selling, general & administrative expenses

    $69.32M
    AKYA annual SGA is $69.32 million

    Depreciation and amortization

    $7.65M
    AKYA annual depreciation & amortization is $7.65 million

    Interest expense

    $10.43M
    AKYA annual interest expense is $10.43 million

    Income tax

    $146.00K
    AKYA annual income tax is $146.00 thousand

    EBIT & EBITDA

    EBIT

    -$44.79M
    AKYA annual earnings before interest & taxes is -$44.79 million

    EBITDA

    -$37.14M
    AKYA annual EBITDA is -$37.14 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $125.00M
    AKYA annual total assets is $125.00 million

    Non current assets

    $48.27M
    AKYA annual long term assets is $48.27 million

    Current assets

    $76.73M
    AKYA annual total current assets is $76.73 million

    Cash and cash equivalents

    $11.78M
    AKYA annual cash & cash equivalents is $11.78 million

    Accounts receivable

    $13.78M
    AKYA annual accounts receivable is $13.78 million

    Inventory

    $24.32M
    AKYA annual inventory is $24.32 million

    Liabilities

    Total liabilities

    $117.41M
    AKYA annual total liabilities is $117.41 million

    Long term liabilities

    $87.97M
    AKYA annual total long term liabilities is $87.97 million

    Current liabilities

    $29.44M
    AKYA annual total current liabilities is $29.44 million

    Accounts payable

    $8.76M
    AKYA annual accounts payable is $8.76 million

    Debt

    Total debt

    $84.15M
    AKYA annual total debt is $84.15 million

    Total debt 1-year change

    -1.82%
    AKYA annual total debt is down -1.82% year-on-year

    Long term debt

    $80.86M
    AKYA annual long term debt is $80.86 million

    Short term debt

    $3.28M
    AKYA annual short term debt is $3.28 million

    Equity & Capital

    Shareholders equity

    $7.59M
    AKYA annual stockholders equity is $7.59 million

    Book value

    $7.59M
    AKYA annual book value is $7.59 million

    Retained earnings

    -$285.44M
    AKYA annual retained earnings is -$285.44 million

    Working capital

    $47.29M
    AKYA annual working capital is $47.29 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$44.10M
    AKYA annual cash flow from operations is -$44.10 million

    Cash from operations 1-year change

    +13.35%
    AKYA annual cash flow from operations is up +13.35% year-on-year

    Cash from investing

    -$24.05M
    AKYA annual cash flow from investing activities is -$24.05 million

    Cash from investing 1-year change

    -818.58%
    AKYA annual cash flow from investing activities is down -818.58% year-on-year

    Cash from financing

    -$3.21M
    AKYA annual cash flow from financing activities is -$3.21 million

    Cash from financing 1-year change

    -105.64%
    AKYA annual cash flow from financing activities is down -105.64% year-on-year

    CAPEX

    CAPEX

    $2.46M
    AKYA annual capital expenditures is $2.46 million

    CAPEX 1-year change

    -32.77%
    AKYA annual capital expenditures is down -32.77% year-on-year

    Free Cash Flow

    Free cash flow

    -$46.56M
    AKYA annual free cash flow is -$46.56 million

    Free cash flow 1-year change

    +14.65%
    AKYA annual free cash flow is up +14.65% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    58.62%
    AKYA annual gross profit margin is 58.62%

    Operating margin

    -50.43%
    AKYA annual operating profit margin is -50.43%

    Net margin

    -67.79%
    AKYA annual net profit margin is -67.79%

    ROA & ROE

    ROA

    -36.26%
    AKYA annual return on assets is -36.26%

    ROE

    -180.44%
    AKYA annual return on equity is -180.44%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    AKYA price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    AKYA price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -10.93
    AKYA price to book ratio is -10.93

    PB ratio Sector rank

    -
    AKYA price to book ratio is unknown

    PS Ratio

    PS ratio

    0.80
    AKYA price to sales ratio is 0.80

    PS ratio Sector rank

    -
    AKYA price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $127.71M
    AKYA enterprise value is $127.71 million

    Enterprise value Sector rank

    -
    AKYA enterprise value is unknown

    EV/EBITDA

    EV/EBITDA

    -4.30
    AKYA EV/EBITDA is -4.30

    EV/EBITDA Sector rank

    -
    AKYA EV/EBITDA is unknown

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    2.61
    AKYA annual current ratio is 2.61

    Quick ratio

    1.78
    AKYA annual quick ratio is 1.78

    Leverage

    Debt to equity

    10.03
    AKYA annual debt to equity ratio is 10.03

    Interest coverage ratio

    -4.29
    AKYA annual interest coverage ratio is -4.29

    Risk & Stability

    Piotroski F-Score

    4
    AKYA piotroski f-score is 4

    Altman Z-Score

    -2.94
    AKYA altman z-score is -2.94

    Analyst ratings

    Recent major analysts updates

    May 19, 25 Canaccord Genuity
    Hold
    Apr 29, 25 Canaccord Genuity
    Hold
    Apr 14, 25 Piper Sandler
    Neutral
    Mar 25, 25 Stephens & Co.
    Equal-Weight
    Mar 18, 25 Stephens & Co.
    Overweight
    Nov 19, 24 Piper Sandler
    Overweight
    Nov 15, 24 Craig-Hallum
    Hold
    Nov 15, 24 Canaccord Genuity
    Buy
    Aug 13, 24 Piper Sandler
    Overweight
    Aug 6, 24 Morgan Stanley
    Equal-Weight

    Institutional Ownership

    Screeners with AKYA included

    No data
    • What is the ticker symbol for Akoya Biosciences, Inc.?
    • Does Akoya Biosciences, Inc. pay dividends?
    • What sector is Akoya Biosciences, Inc. in?
    • What industry is Akoya Biosciences, Inc. in?
    • What country is Akoya Biosciences, Inc. based in?
    • When did Akoya Biosciences, Inc. go public?
    • Is Akoya Biosciences, Inc. in the S&P 500?
    • Is Akoya Biosciences, Inc. in the NASDAQ 100?
    • Is Akoya Biosciences, Inc. in the Dow Jones?
    • When was Akoya Biosciences, Inc.'s last earnings report?
    • When does Akoya Biosciences, Inc. report earnings?

    What is the ticker symbol for Akoya Biosciences, Inc.?

    The ticker symbol for Akoya Biosciences, Inc. is NASDAQ:AKYA

    Does Akoya Biosciences, Inc. pay dividends?

    No, Akoya Biosciences, Inc. does not pay dividends

    What sector is Akoya Biosciences, Inc. in?

    Akoya Biosciences, Inc. is in the Healthcare sector

    What industry is Akoya Biosciences, Inc. in?

    Akoya Biosciences, Inc. is in the Medical Instruments & Supplies industry

    What country is Akoya Biosciences, Inc. based in?

    Akoya Biosciences, Inc. is headquartered in United States

    When did Akoya Biosciences, Inc. go public?

    Akoya Biosciences, Inc.'s initial public offering (IPO) was on April 16, 2021

    Is Akoya Biosciences, Inc. in the S&P 500?

    No, Akoya Biosciences, Inc. is not included in the S&P 500 index

    Is Akoya Biosciences, Inc. in the NASDAQ 100?

    No, Akoya Biosciences, Inc. is not included in the NASDAQ 100 index

    Is Akoya Biosciences, Inc. in the Dow Jones?

    No, Akoya Biosciences, Inc. is not included in the Dow Jones index

    When was Akoya Biosciences, Inc.'s last earnings report?

    Akoya Biosciences, Inc.'s most recent earnings report was on August 5, 2025

    When does Akoya Biosciences, Inc. report earnings?

    The date for Akoya Biosciences, Inc.'s next earnings report has not been announced yet
    On this page